237 related articles for article (PubMed ID: 21853118)
1. Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets.
Pachikian BD; Essaghir A; Demoulin JB; Neyrinck AM; Catry E; De Backer FC; Dejeans N; Dewulf EM; Sohet FM; Portois L; Deldicque L; Molendi-Coste O; Leclercq IA; Francaux M; Carpentier YA; Foufelle F; Muccioli GG; Cani PD; Delzenne NM
PLoS One; 2011; 6(8):e23365. PubMed ID: 21853118
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum stress leads to lipid accumulation through upregulation of SREBP-1c in normal hepatic and hepatoma cells.
Fang DL; Wan Y; Shen W; Cao J; Sun ZX; Yu HH; Zhang Q; Cheng WH; Chen J; Ning B
Mol Cell Biochem; 2013 Sep; 381(1-2):127-37. PubMed ID: 23703028
[TBL] [Abstract][Full Text] [Related]
3. Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways.
Pachikian BD; Essaghir A; Demoulin JB; Catry E; Neyrinck AM; Dewulf EM; Sohet FM; Portois L; Clerbaux LA; Carpentier YA; Possemiers S; Bommer GT; Cani PD; Delzenne NM
Mol Nutr Food Res; 2013 Feb; 57(2):347-59. PubMed ID: 23203768
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition.
Pachikian BD; Neyrinck AM; Cani PD; Portois L; Deldicque L; De Backer FC; Bindels LB; Sohet FM; Malaisse WJ; Francaux M; Carpentier YA; Delzenne NM
BMC Physiol; 2008 Dec; 8():21. PubMed ID: 19046413
[TBL] [Abstract][Full Text] [Related]
5. Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome.
Libby AE; Bales E; Orlicky DJ; McManaman JL
J Biol Chem; 2016 Nov; 291(46):24231-24246. PubMed ID: 27679530
[TBL] [Abstract][Full Text] [Related]
6. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
[TBL] [Abstract][Full Text] [Related]
7. RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.
Cui XB; Luan JN; Chen SY
J Biol Chem; 2015 Aug; 290(33):20387-95. PubMed ID: 26134570
[TBL] [Abstract][Full Text] [Related]
8. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
López-Oliva ME; Garcimartin A; Muñoz-Martínez E
Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
[TBL] [Abstract][Full Text] [Related]
9. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.
Pettinelli P; Del Pozo T; Araya J; Rodrigo R; Araya AV; Smok G; Csendes A; Gutierrez L; Rojas J; Korn O; Maluenda F; Diaz JC; Rencoret G; Braghetto I; Castillo J; Poniachik J; Videla LA
Biochim Biophys Acta; 2009 Nov; 1792(11):1080-6. PubMed ID: 19733654
[TBL] [Abstract][Full Text] [Related]
10. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
[TBL] [Abstract][Full Text] [Related]
11. Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression.
Du R; Xue J; Wang HB; Zhang Y; Xie ML
Eur J Pharmacol; 2011 Sep; 666(1-3):183-8. PubMed ID: 21620823
[TBL] [Abstract][Full Text] [Related]
12. The role of hepatic liver X receptor α- and sterol regulatory element binding protein-1c-mediated lipid disorder in the pathogenesis of non-alcoholic steatohepatitis in rats.
Ai ZL; Zhu CH; Min M; Wang J; Lan CH; Fan LL; Sun WJ; Chen DF
J Int Med Res; 2011; 39(4):1219-29. PubMed ID: 21986124
[TBL] [Abstract][Full Text] [Related]
13. Low abundance of insulin-induced gene 1 contributes to SREBP-1c processing and hepatic steatosis in dairy cows with severe fatty liver.
Zhu Y; Lei L; Wang X; Jiang Q; Loor JJ; Kong F; Chen L; Li J; Zhao C; Liu M; Liu G; Li X
J Dairy Sci; 2023 Aug; 106(8):5626-5635. PubMed ID: 37291038
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
[TBL] [Abstract][Full Text] [Related]
15. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease.
Bai Q; Zhang X; Xu L; Kakiyama G; Heuman D; Sanyal A; Pandak WM; Yin L; Xie W; Ren S
Metabolism; 2012 Jun; 61(6):836-45. PubMed ID: 22225954
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
[TBL] [Abstract][Full Text] [Related]
17. Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass.
Knebel B; Haas J; Hartwig S; Jacob S; Köllmer C; Nitzgen U; Muller-Wieland D; Kotzka J
PLoS One; 2012; 7(2):e31812. PubMed ID: 22363740
[TBL] [Abstract][Full Text] [Related]
18. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
Gao M; Bu L; Ma Y; Liu D
PLoS One; 2013; 8(6):e65641. PubMed ID: 23762402
[TBL] [Abstract][Full Text] [Related]
19. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet.
Kasbi-Chadli F; Ferchaud-Roucher V; Krempf M; Ouguerram K
Eur J Nutr; 2016 Mar; 55(2):589-599. PubMed ID: 25787885
[TBL] [Abstract][Full Text] [Related]
20. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]